Reuters logo
Valeant offers to buy Botox maker Allergan
April 22, 2014 / 12:01 PM / 3 years ago

Valeant offers to buy Botox maker Allergan

April 22 (Reuters) - Canada’s Valeant Pharmaceuticals International Inc said it offered to buy Botox maker Allergan Inc to boost its skin and eye-care portfolio.

Valeant said it had offered to pay $48.30 per share in cash and 0.83 of its common share for each Allergan share.

The company said Bill Ackman’s Pershing Square, Allergan’s largest shareholder with a 9.7 percent stake, supported the deal. (Reporting by Esha Dey in Bangalore; Editing by Saumyadeb Chakrabarty)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below